Literature DB >> 18236905

A study of pulmonary tuberculosis in the elderly.

S K Das1, R S Mukherjee, I N Ghosh, A K Halder, S K Saha.   

Abstract

The incidence of tuberculosis (TB) is increasing globally. The diagnbsis of TB in elderly is often delayed due to the atypical presentation. There is also therapeutic problems because of presence of comorbidity, nutritional and socio-economic factors and increased incidence of adverse drug reactions and mortality. A prospective study was conducted among patients presenting with pulmonary tuberculosis at the department of TB and respiratory medicine in a tertiary care hospital between January, 2006 to July, 2006. Thirty patients aged more than 65 years were studied for their clinical characteristics, comorbid illnesses, sputum status, radiological features and adverse drug reactions. They were contrasted against the same parameters in 40 patients aged 65 years or less. The study showed that pulmonary TB in the elderly is characterised by (a) atypical symptoms, (b) more extensive radiological lesion with lower zone preponderance, (c) higher sputum positivity, (d) more frequent comorbidity, (e) more frequent side-effects and (f) higher mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18236905

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  3 in total

1.  Tuberculosis a re-emerging disease.

Authors:  Saverio De Lorenzo; Simon Tiberi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

2.  APACHE-II score for anti-tuberculosis tolerance in critically ill patients: a retrospective study.

Authors:  Junke Qiu; Caihong Wang; Xiaohong Pan; Lei Pan; Xiaoqing Huang; Jiekun Xu; Xiaobo Ji; Minjie Mao
Journal:  BMC Infect Dis       Date:  2019-02-04       Impact factor: 3.090

3.  Population aging and migrant workers: bottlenecks in tuberculosis control in rural China.

Authors:  Sumedh Bele; Wei Jiang; Hui Lu; Hua You; Hong Fan; Lifang Huang; Qungang Wang; Hongbing Shen; Jianming Wang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.